{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:09:11Z","timestamp":1784117351845,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009068","name":"University of Bern","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009068","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.modpat.2026.101010","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:29:18Z","timestamp":1778282958000},"page":"101010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged Survival in Pancreatic Adenocarcinoma"],"prefix":"10.1016","volume":"39","author":[{"given":"Anna Silvia","family":"Wenning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Br\u00e4utigam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Aeschbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Animesh","family":"Acharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Gloor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurel","family":"Perren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4833-1373","authenticated-orcid":false,"given":"Eva","family":"Karamitopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2026.101010_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.modpat.2026.101010_bib2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","article-title":"Pancreatic cancer: pathogenesis, screening, diagnosis and treatment","volume":"163","author":"Wood","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.modpat.2026.101010_bib3","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.ejso.2019.05.031","article-title":"Postoperative surveillance of pancreatic cancer patients","volume":"45","author":"Daamen","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.modpat.2026.101010_bib4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.modpat.2026.101010_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","article-title":"Electronic address: andrew_aguirre@dfci.harvard.edu; Cancer Genome Atlas Research Network. Integrated genomic characterization of pancreatic ductal adenocarcinoma","volume":"32","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.modpat.2026.101010_bib6","article-title":"Association of RNF43 genetic alterations with BRAFV600E and MSIhigh in colorectal cancer","volume":"8","author":"Vogel","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.modpat.2026.101010_bib7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/path.4134","article-title":"RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary","volume":"229","author":"Ryland","year":"2013","journal-title":"J Pathol"},{"key":"10.1016\/j.modpat.2026.101010_bib8","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/j.gastro.2021.12.273","article-title":"Loss of Rnf43 accelerates Kras-mediated neoplasia and remodels the tumor immune microenvironment in pancreatic adenocarcinoma","volume":"162","author":"Hosein","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.modpat.2026.101010_bib9","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1136\/gutjnl-2022-329371","article-title":"Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancer","volume":"72","author":"Karamitopoulou","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.modpat.2026.101010_bib10","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-24-0368","article-title":"Spatial heterogeneity of immune regulators drives dynamic changes in local immune responses, affecting disease outcomes in pancreatic cancer","volume":"30","author":"Karamitopoulou","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2026.101010_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejca.2022.03.033","article-title":"High tumor mutational burden (TMB) identifies a microsatellite stable pancreatic cancer subset with prolonged survival and strong anti-tumor immunity","volume":"169","author":"Karamitopoulou","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.modpat.2026.101010_bib12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature24462","article-title":"Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer","volume":"551","author":"Balachandran","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.modpat.2026.101010_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41586-022-04735-9","article-title":"Neoantigen quality predicts immunoediting in survivors of pancreatic cancer","volume":"606","author":"\u0141uksza","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.modpat.2026.101010_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/17474124.2024.2322648","article-title":"Next-generation therapies for pancreatic cancer","volume":"18","author":"Buckley","year":"2024","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.modpat.2026.101010_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100515","article-title":"Moving forward on tumor pathology research reporting: a guide for pathologists from the World Health Organization classification of tumors living evidence gap map by tumour type group","volume":"37","author":"Colling","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2026.101010_bib16","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1158\/2326-6066.CIR-21-0144","article-title":"PD-1\/PD-L1-associated immunoarchitectural patterns stratify pancreatic cancer patients into prognostic\/predictive subgroups","volume":"9","author":"Karamitopoulou","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.modpat.2026.101010_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/gutjnl-2019-318217","article-title":"Morphological classification of pancreatic ductal adenocarcinoma that predicts molecular subtypes and correlates with clinical outcome","volume":"69","author":"Kalimuthu S","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.modpat.2026.101010_bib18","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ejca.2012.10.022","article-title":"Tumour budding is a strong and independent prognostic factor in pancreatic cancer","volume":"49","author":"Karamitopoulou","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.modpat.2026.101010_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/jgh.12752","article-title":"Detailed analysis of epithelial\u2013mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma","volume":"30","author":"Kohler","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.modpat.2026.101010_bib20","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/s41416-018-0093-y","article-title":"Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma","volume":"118","author":"Lohneis","year":"2018","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.modpat.2026.101010_bib21","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/modpathol.2017.46","article-title":"Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016","volume":"30","author":"Lugli","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2026.101010_bib22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation","volume":"28","author":"Trapnell","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.modpat.2026.101010_bib23","doi-asserted-by":"crossref","first-page":"12214","DOI":"10.1096\/fj.202000363RR","article-title":"Basal-like and classical cells coexist in pancreatic cancer revealed by single-cell analysis on biopsy-derived pancreatic cancer organoids from the classical subtype","volume":"34","author":"Juiz","year":"2020","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.modpat.2026.101010_bib24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s10194-025-02058-4","article-title":"Fibroblast reprogramming in the dura mater of NTG-induced migraine-related chronic hypersensitivity model drives monocyte infiltration via Angptl1-dependent stromal signaling","volume":"26","author":"Guo","year":"2025","journal-title":"J Headache Pain"},{"issue":"2","key":"10.1016\/j.modpat.2026.101010_bib25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41588-019-0566-9","article-title":"Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution","volume":"52","author":"Chan-Seng-Yue","year":"2020","journal-title":"Nat Genet"},{"key":"10.1016\/j.modpat.2026.101010_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101305","article-title":"Lymphocyte-activation gene 3 (LAG3): the next immune checkpoint receptor","volume":"42","author":"Ruffo","year":"2019","journal-title":"Semin Immunol"},{"key":"10.1016\/j.modpat.2026.101010_bib27","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1038\/s41467-020-18828-4","article-title":"Structural characterization of the ICOS\/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies","volume":"11","author":"Rujas","year":"2020","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.modpat.2026.101010_bib28","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/ng.3398","article-title":"Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma","volume":"47","author":"Moffitt","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.modpat.2026.101010_bib29","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/s41467-024-55424-2","article-title":"Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms","volume":"16","author":"Sivakumar","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.modpat.2026.101010_bib30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101010_bib31","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1038\/s41598-023-30294-8","article-title":"The tumor biological significance of RNF43 and LRP1B in gastric cancer is complex and context-dependent","volume":"13","author":"Holm","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.modpat.2026.101010_bib32","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.21037\/jgo.2019.08.08","article-title":"Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancers","volume":"10","author":"Mody","year":"2019","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.modpat.2026.101010_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12029-023-00965-w","article-title":"T cell exhaustion and activation markers in pancreatic cancer: a systematic review","volume":"55","author":"Mishra","year":"2024","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.modpat.2026.101010_bib34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.omto.2021.05.006","article-title":"CD133 mRNA-transfected dendritic cells induce coordinated cytotoxic and helper T cell responses against breast cancer stem cells","volume":"22","author":"Tay","year":"2021","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.modpat.2026.101010_bib35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/2326-6066.CIR-21-0454","article-title":"Identification of immunogenic MHC class II human HER3 peptides that mediate anti-HER3 CD4+ Th1 responses and potential use as a cancer vaccine","volume":"10","author":"Basu","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.modpat.2026.101010_bib36","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1158\/1078-0432.CCR-21-2762","article-title":"The PD-L1\/4-1BB bispecific antibody-anticalin fusion protein PRS-344\/S095012 elicits strong T-cell stimulation in a tumor-localized manner","volume":"28","author":"Peper-Gabriel","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"3_suppl","key":"10.1016\/j.modpat.2026.101010_bib37","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1200\/JCO.2024.42.3_suppl.698","article-title":"The impact of Wnt pathway alterations including RNF43, GNAS, CTNNB1, and APC on prognosis and potential therapeutic vulnerability in pancreatic adenocarcinoma (PDAC)","volume":"42","author":"Takebe","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.modpat.2026.101010_bib38","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231220600","article-title":"Clinical and molecular characteristics of RNF43 mutations as promising prognostic biomarkers in colorectal cancer","volume":"16","author":"Huang","year":"2024","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101010_bib39","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s40001-023-01383-1","article-title":"Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker","volume":"28","author":"Xu","year":"2023","journal-title":"Eur J Med Res"},{"issue":"6","key":"10.1016\/j.modpat.2026.101010_bib40","first-page":"1853","article-title":"RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer","volume":"43","author":"Matsumoto","year":"2020","journal-title":"Oncol Rep"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:22:50Z","timestamp":1784114570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226000530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0893395226000530"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101010","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNF43 Mutations Are Associated With the Classical Molecular Subtype, Vigorous Antitumor Immune Responses, and Prolonged Survival in Pancreatic Adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101010"}}